Treatment options for tic disorders

被引:9
|
作者
Rizzo, Renata [1 ]
Gulisano, Mariangela [1 ]
机构
[1] Catania Univ, Dept Clin & Expt Med, Child & Adolescent Psychiat Sect, Via Santa Sofia 78, I-95123 Catania, Italy
关键词
Alpha-2; agonists; antipsychotics; tics; Tourette syndrome; vesicular monoamine transporter-2 inhibitors; PLACEBO-CONTROLLED TRIAL; OPEN-LABEL OLANZAPINE; LA-TOURETTE-SYNDROME; DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; PHARMACOLOGICAL-TREATMENT; CHILDREN; ADOLESCENTS; RISPERIDONE; CLONIDINE;
D O I
10.1080/14737175.2020.1698950
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder, characterized by the presence of multiple motor and, at least one, phonic tics, for more than one year, beginning before 18 years of age; its treatment is often a challenge for the clinician Areas covered: GTS treatment requires a multidisciplinary management to treat each patient's symptom. Although individuals with GTS often have comorbid psychiatric disorders, the focus of this review will only be on the management of tics. Expert opinion: The authors summarized the steps that clinicians should follow treating GTS patient; the impact of the tics on a patients' life should be the first step; different patients could present different levels of tolerance to the symptoms. Second, comorbidities should be considered before starting a treatment for tic. Finally, clinicians must focus the attention of the patient and family, on the length of the treatment and the duration of time after which the effects of the drug will occur. Before the treatment, the potential side effects must be mentioned to the parents, and the choice of treatment must be made in the light of the patient's tolerance to these.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 50 条
  • [1] Treatment of tic disorders
    Mueller-Vahl, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S149 - S149
  • [2] TREATMENT OF TIC DISORDERS
    ROTHENBERGER, A
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 1984, 12 (03): : 284 - 301
  • [3] Pharmacologic treatment of tic disorders
    Scahill, L
    Chappell, PB
    King, RA
    Leckman, JF
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 9 (01) : 99 - +
  • [4] TREATMENT OF TIC DISORDERS WITH CLONAZEPAM
    VOULTERS, L
    BRESSMAN, SB
    FAHN, S
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (02) : 172 - 173
  • [5] TIC TALK: RESEARCH UPDATES IN THE PHENOMENOLOGY AND TREATMENT OF TIC DISORDERS
    McGuire, Joseph
    Piacentini, John
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S304 - S304
  • [6] PIMOZIDE TREATMENT OF TIC AND TOURETTE DISORDERS
    SHAPIRO, AK
    SHAPIRO, E
    FULOP, G
    PEDIATRICS, 1987, 79 (06) : 1032 - 1039
  • [7] Tic disorders: from pathophysiology to treatment
    L. Rampello
    A. Alvano
    G. Battaglia
    V. Bruno
    R. Raffaele
    F. Nicoletti
    Journal of Neurology, 2006, 253 : 1 - 15
  • [8] Tic disorders: from pathophysiology to treatment
    Rampello, L
    Alvano, A
    Battaglia, G
    Bruno, V
    Raffaele, R
    Nicoletti, F
    JOURNAL OF NEUROLOGY, 2006, 253 (01) : 1 - 15
  • [9] Pharmacological treatment of tic disorders and Tourette Syndrome
    Roessner, Veit
    Schoenefeld, Katja
    Buse, Judith
    Bender, Stephan
    Ehrlich, Stefan
    Muenchau, Alexander
    NEUROPHARMACOLOGY, 2013, 68 : 143 - 149
  • [10] ADJUNCTIVE CLONAZEPAM TREATMENT OF TIC SYMPTOMS IN CHILDREN WITH COMORBID TIC DISORDERS AND ADHD
    STEINGARD, RJ
    GOLDBERG, M
    LEE, D
    DEMASO, DR
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1994, 33 (03): : 394 - 399